Attached files
file | filename |
---|---|
8-K - FORM 8-K - Brooks Automation, Inc. | b87392e8vk.htm |
EX-2.1 - EX-2.1 - Brooks Automation, Inc. | b87392exv2w1.htm |
Exhibit 99.1
Press Release
For Immediate Release
Brooks Automation Announces Purchase Of Nexus Biosystems, Inc.
Chelmsford, Massachusetts July 25, 2011 Brooks Automation, Inc.
(Nasdaq: BRKS) announced today that it had completed the acquisition of Nexus Biosystems,
Inc. (Nexus) the Poway, California based global market leader in automated compound and sample
management solutions for life sciences. The net cash purchase price was $79 million.
Additionally, the Company paid approximately $6.7 million for the value of the unrestricted cash
held by Nexus at closing. For the trailing twelve months ended June 30, 2011, Nexus generated
revenues of $36 million.
Dr. Steve Schwartz, President & CEO of Brooks, stated Nexus represents an important next step in
our strategy to build a meaningful position in a rapid, secular growth market. Together with our
other recent acquisition, RTS Life Sciences, and our core technical competencies at Brooks, we plan
to build Brooks Life Science Systems into the market and innovation leader in Biobanking and
Compound Sample Management. With Nexus operations on the West Coast and meaningful sales and
service locations in Switzerland, Japan and Germany complementing our existing Life Science Systems
direct channel presence on the East Coast and in the UK we will have broad global reach.
Nexus has developed a proven technology position in their systems, consumables and service
offerings. Combined with RTS they will have developed the leading installed base of Automated
Biobanks and Compound Sample Management Systems placed in service over the past decade., continued
Dr. Schwartz.
John Lillig, CEO of Nexus Biosystems, commented, We are very excited about joining the Brooks team
and we are also very much looking forward to joining with our sample management colleagues from
RTS. Both Brooks and Nexus have been strong technology innovators. Combining the technological and
global support strengths of our two companies will help to accelerate the ongoing product
development, commercialization and customer support of our expanding sample management solutions
Martin S. Headley, Executive Vice-President and Chief Financial Officer observed, Nexus has
attractive financial attributes including a gross margin profile that is favorable to the Brooks
average and modest fixed asset and working capital requirements. We will be making meaningful
development expenditures in next generation automated sample management products over the next
twelve to fifteen months that will moderate operate margins from the attractive levels we expect to
see thereafter.
Brooks
Automation, Inc. w 15 Elizabeth Drive w Chelmsford, Massachusetts 01824 w (978)262-2400 w www.brooks.com.
Brooks
Automation Announces purchase of Nexus Biosystems, Inc. .... page two
About Brooks Automation, Inc.
Brooks is a leading worldwide provider of automation, vacuum and instrumentation solutions to
markets where our technologies provide superior value in controlled environments; our engineering
competencies provide our customers with speed to market; and our global service capabilities ensure
rapid uptime response. Global semiconductor manufacturing is our heritage and the largest market
we currently serve. However, through our product initiatives and business acquisitions, we are
increasingly meeting the needs of customers across a broad spectrum of applications in life
sciences, analytical & research markets, and clean energy solutions. For more information go to
www.brooks.com.
Safe Harbor Statement under Section 21E of the Securities Exchange Act of 1934
Some statements in this release are forward-looking statements made under Section 21E of the
Securities Exchange Act of 1934. These statements are neither promises nor guarantees but involve
risks and uncertainties, both known and unknown, that could cause Brooks financial and business
results to differ materially from our expectations. They are based on the facts known to management
at the time they are made. These forward-looking statements include statements regarding our
revenue and operating margin expectations, our ability to develop further our business in new and
adjacent markets, and our ability to achieve financial success in the future. Factors that could
cause results to differ from our expectations include the following: volatility of the industries
the Company serves, particularly the semiconductor industry; our possible inability to meet demand
for our products due to difficulties in obtaining components and materials from our suppliers -
particularly those manufacturing in Japan in required quantities and of required quality; the
inability of customers to make payments to us when due; the timing and effectiveness of cost
reduction and cost control measures; price competition; disputes concerning intellectual property;
continuing uncertainties in global political and economic conditions, and other factors and other
risks that we have described in our filings with the Securities and Exchange Commission, including
but not limited to our Annual Report on Form 10-K, current reports on Form 8-K and our quarterly
reports on Form 10-Q. As a result we can provide no assurance that our future results will not be
materially different from those projected. Brooks expressly disclaims any obligation or undertaking
to release publicly any updates or revisions to any such statement to reflect any change in our
expectations or any change in events, conditions or circumstances on which any such statement is
based. Brooks undertakes no obligation to update the information contained in this press release.
Contact:
Barbara Culhane
Corporate Marketing Manager
Brooks Automation, Inc.
978-262-2400
www.brooks.com
Barbara Culhane
Corporate Marketing Manager
Brooks Automation, Inc.
978-262-2400
www.brooks.com
Brooks
Automation, Inc. w 15 Elizabeth Drive w Chelmsford, Massachusetts 01824 w (978)262-2400 w www.brooks.com.